Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Accounts Payables: 2020-2025

Historic Accounts Payables for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to $2,654.

  • Molecular Partners Ag's Accounts Payables fell 3.47% to $2,654 in Q3 2025 from the same period last year, while for Sep 2025 it was $2,654, marking a year-over-year decrease of 3.47%. This contributed to the annual value of $2.1 million for FY2024, which is 42.91% up from last year.
  • As of Q3 2025, Molecular Partners Ag's Accounts Payables stood at $2,654, which was up 11.47% from $2,381 recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Accounts Payables ranged from a high of $8.0 million in Q4 2021 and a low of $2,381 during Q2 2025.
  • In the last 3 years, Molecular Partners Ag's Accounts Payables had a median value of $3,046 in 2023 and averaged $331,365.
  • In the last 5 years, Molecular Partners Ag's Accounts Payables plummeted by 72.24% in 2022 and then skyrocketed by 41.74% in 2024.
  • Over the past 5 years, Molecular Partners Ag's Accounts Payables (Quarterly) stood at $8.0 million in 2021, then tumbled by 72.24% to $2.2 million in 2022, then crashed by 32.70% to $1.5 million in 2023, then skyrocketed by 41.74% to $2.1 million in 2024, then dropped by 3.47% to $2,654 in 2025.
  • Its Accounts Payables was $2,654 in Q3 2025, compared to $2,381 in Q2 2025 and $2,665 in Q1 2025.